Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-582-3p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 376, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
FHIT hsa-miR-582-3p low: 1 high: 0 1 1 1 -
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Yu-Xiang Lin et al. 2011 RP Kidney HEK293T HEK293T N/A
Location Method Result Regulation Validation Type Source
chr3:59749530-59749552 Luciferase Reporter Assay NEGATIVE DIRECT TarBase 8.0
CBX6 hsa-miR-582-3p low: 0 high: 4 1 1 1 0.501
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr22:38864384-38864412 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr22:38864384-38864412 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr22:38864384-38864412 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr22:38863859-38863876 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLC16A1 hsa-miR-582-3p low: 0 high: 3 3 3 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:112913762-112913788 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr1:112917651-112917677 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:112913762-112913788 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DNAJC9 hsa-miR-582-3p low: 0 high: 3 2 2 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr10:73242970-73242997 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A N/A
Location Method Result Regulation Validation Type Source
chr10:73242970-73242997 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr10:73242970-73242997 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RREB1 hsa-miR-582-3p low: 0 high: 3 2 2 2 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr6:7250845-7250866 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr6:7250718-7250729 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:7250845-7250866 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RGMB hsa-miR-582-3p low: 0 high: 3 1 1 1 0.572
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr5:98794097-98794125 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:98794097-98794125 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr5:98794097-98794125 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PKD1 hsa-miR-582-3p low: 0 high: 3 1 1 1 -
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr16:2090193-2090209 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:2090193-2090209 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:2090193-2090209 HITS-CLIP POSITIVE DIRECT TarBase 7.0
UBE3C hsa-miR-582-3p low: 0 high: 2 2 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr7:157268524-157268534 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr7:157183914-157183942 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RNF19A hsa-miR-582-3p low: 0 high: 2 2 2 2 0.858
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr8:100257174-100257192 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr8:100257174-100257192 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RC3H2 hsa-miR-582-3p low: 0 high: 2 1 2 1 0.618
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:122849272-122849283 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:122849272-122849283 PAR-CLIP POSITIVE DIRECT TarBase 7.0
ABCC9 hsa-miR-582-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:21923645-21923667 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:21923645-21923667 PAR-CLIP POSITIVE DIRECT TarBase 7.0
TGFBR3 hsa-miR-582-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr1:91680479-91680488 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:91680479-91680488 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SRCAP hsa-miR-582-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr16:30704092-30704118 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr16:30724790-30724809 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PABPN1 hsa-miR-582-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr14:23325072-23325078 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr14:23325072-23325078 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ADNP hsa-miR-582-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A N/A
Location Method Result Regulation Validation Type Source
chr20:50892947-50892957 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:50893493-50893512 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NOP56 hsa-miR-582-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr20:2655390-2655402 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr20:2655390-2655402 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CAV1 hsa-miR-582-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr7:116560820-116560830 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A N/A
Location Method Result Regulation Validation Type Source
chr7:116560820-116560830 PAR-CLIP POSITIVE DIRECT TarBase 7.0
DKK1 hsa-miR-582-3p low: 0 high: 2 2 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr10:52316794-52316812 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr10:52316794-52316812 PAR-CLIP POSITIVE DIRECT TarBase 7.0
COPZ1 hsa-miR-582-3p low: 0 high: 2 1 1 1 0.454
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr12:54351704-54351713 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A N/A
Location Method Result Regulation Validation Type Source
chr12:54351704-54351713 PAR-CLIP POSITIVE DIRECT TarBase 7.0
PTBP3 hsa-miR-582-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr9:112219620-112219631 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr9:112219233-112219252 HITS-CLIP POSITIVE DIRECT TarBase 7.0